SCHEMBL1695196

SCHEMBL1695196

N#Cc1c(N)ncnc1NCCc1nc2ccc(F)cc2cc1C(=O)NCc1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
ROCK2 O75116 1/20 0.43
CSF1R P07333 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
CSNK1D P48730 1/20 0.43
MAPK10 P53779 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
PDPK1 O15530 2/20 0.42
PIK3CD O00329 11/20 0.42
PIK3CG P48736 9/20 0.42
PIK3CB P42338 8/20 0.42
PIK3CA P42336 7/20 0.42
PIK3R1 P27986 1/20 0.42
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MMP13 P45452 1/20 0.40
SCN9A Q15858 1/20 0.40
KDM4E B2RXH2 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695369 0.92 PIK3CD (0.45) MAPK8MAPK9MAPK10PIK3CDPIK3CG
SCHEMBL1694804 0.87 MAPK1 (0.43) MAPK1ROCK2CSF1RMAPK8MAPK9
SCHEMBL1695028 0.86 PIK3CD (0.46) PDPK1PIK3CDPIK3CGPIK3CBPIK3CA
SCHEMBL1694926 0.86 PIK3CD (0.50) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL1694983 0.85 PIK3CD (0.48) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL1694825 0.83 PIK3CD (0.44) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL1695192 0.83 PIK3CD (0.58) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL10146881 0.83 PIK3CD (0.58) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL1695189 0.82 PIK3CD (0.45) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL1695193 0.82 PIK3CD (0.45) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588467-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003274-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed